Conv. Plasma
Nigella Sativa
Peg.. Lambda

All HCQ studies
Meta analysis
Home COVID-19 treatment researchHCQHCQ (more..)
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta
Cannabidiol Meta Molnupiravir Meta
Colchicine Meta
Conv. Plasma Meta
Curcumin Meta Nigella Sativa Meta
Ensovibep Meta Nitazoxanide Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Peg.. Lambda Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Ivermectin Meta
Lactoferrin Meta

All Studies   Meta Analysis   Recent:  
0 0.5 1 1.5 2+ Mortality 11% Improvement Relative Risk HCQ for COVID-19  Hall et al.  ICU PATIENTS Is very late treatment with HCQ beneficial for COVID-19? Retrospective 505 patients in the USA Lower mortality with HCQ (not stat. sig., p=0.31) Hall et al., The Annals of Thoracic Su.., Feb 2022 Favors HCQ Favors control

Multi-institutional Analysis of 505 COVID-19 Patients Supported with ECMO: Predictors of Survival

Hall et al., The Annals of Thoracic Surgery, doi:10.1016/j.athoracsur.2022.01.043
Feb 2022  
  Source   PDF   All Studies   Meta AnalysisMeta
Retrospective 505 ECMO patients showing no significant difference in mortality in unadjusted results. This study is excluded in the after exclusion results of meta analysis: unadjusted results with no group details.
risk of death, 11.2% lower, RR 0.89, p = 0.31, treatment 31 of 56 (55.4%), control 280 of 449 (62.4%), NNT 14.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Hall et al., 18 Feb 2022, retrospective, USA, peer-reviewed, 15 authors.
All Studies   Meta Analysis   Submit Updates or Corrections
This PaperHCQAll
Multi-institutional Analysis of 505 Patients With Coronavirus Disease-2019 Supported With Extracorporeal Membrane Oxygenation: Predictors of Survival
Celeste A Hall, MD Jeffrey P Jacobs, MSA Alfred H Stammers, James D St. Louis, J W Awori Hayanga, MD Michael S Firstenberg, CCP Linda B Mongero, PhD Eric A Tesdahl, MD Keshava Rajagopal, PhD Faisal H Cheema, CCP Kirti Patel, CCP Tom Coley, CCP Anthony K Sestokas, PhD Marvin J Slepian, MD Vinay Badhwar
The Annals of Thoracic Surgery, doi:10.1016/j.athoracsur.2022.01.043
This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
Badulak, Antonini, Stead, Extracorporeal Membrane Oxygenation for COVID-19: Updated 2021 Guidelines from the Extracorporeal Life Support Organization, ASAIO J
Barbaro, Maclaren, Boonstra, Extracorporeal membrane oxygenation support in COVID-19: an international cohort study of the Extracorporeal Life Support Organization registry, Lancet
Bartlett, Ogino, Brodie, Initial ELSO Guidance Document: ECMO for COVID-19 Patients with Severe Cardiopulmonary Failure, ASAIO J
Basil, Katzen, Engler, The Cellular and Physiological Basis for Lung Repair and Regeneration: Past, Present, and Future, Cell Stem Cell
Clerkin, Fried, Raikhelkar, COVID-19 and Cardiovascular Disease, Circulation
Core, R: A language and environment for statistical computing
Harrell, Dupont, Others, Hmisc': Harrell Miscellaneous. R package version 4
Harrell, rmsb': Bayesian Regression Modeling Strategies
Henry, COVID-19, ECMO, and lymphopenia: a word of caution, Lancet Respir Med
Jacobs, Falasa, Machuca, Commentary: Extracorporeal membrane oxygenation for patients with refractory Coronavirus Disease 2019: What do we know and what do we need to learn?, J Thorac Cardiovasc Surg
Jacobs, Stammers, Louis Etal, Extracorporeal Membrane Oxygenation in the Treatment of Severe Pulmonary and Cardiac Compromise in Coronavirus Disease 2019: Experience with 32 Patients, ASAIO J
Jacobs, Stammers, Louis, Multi-institutional Analysis of 100 Consecutive Patients with COVID-19 and Severe Pulmonary Compromise Treated with Extracorporeal Membrane Oxygenation: Outcomes and Trends Over Time, ASAIO J
Jacobs, Stammers, Louis, Multi-institutional Analysis of 200 COVID-19 Patients treated with ECMO: Outcomes and Trends, Ann Thorac Surg, doi:10.1016/j.athoracsur.2021.06.026
Kon, Smith, Chang, Extracorporeal Membrane Oxygenation Support in Severe COVID-19, Ann Thorac Surg
Kotton, Morrisey, Lung regeneration: mechanisms, applications and emerging stem cell populations, Nat Med
Kumar, Hu, Yamamoto, Distal airway stem cells yield alveoli in vitro and during lung regeneration following H1N1 influenza infection, Cell
Liu, Liu, Cui, Lung regeneration by multipotent stem cells residing at the bronchioalveolar-duct junction, Nat Genet
Loyalka, Cheema, Rao, Rame, Rajagopal, Early Usage of Extracorporeal Membrane Oxygenation in the Absence of Invasive Mechanical Ventilation to Treat COVID-19-related Hypoxemic Respiratory Failure, ASAIO J
Madjid, Safavi-Naeini, Solomon, Vardeny, Potential Effects of Coronaviruses on the Cardiovascular System: A Review, JAMA Cardiol
Rajagopal, Keller, Akkanti, Advanced Pulmonary and Cardiac Support of COVID-19 Patients: Emerging Recommendations From ASAIO-A "Living Working Document, ASAIO J
Rajagopal, Keller, Akkanti, Advanced Pulmonary and Cardiac Support of COVID-19 Patients: Emerging Recommendations From ASAIO-a Living Working Document, Circ Heart Fail
Shih, Dimaio, Squiers, Venovenous extracorporeal membrane oxygenation for patients with refractory coronavirus disease 2019 (COVID-19): Multicenter experience of referral hospitals in a large health care system, J Thorac Cardiovasc Surg, doi:10.1016/j.jtcvs.2020.11.073
Shih, Squiers, Dimaio, Outcomes of Extracorporeal Membrane Oxygenation in Patients With Severe Acute Respiratory Distress Syndrome Caused by COVID-19 Versus Influenza, Ann Thorac Surg, doi:10.1016/j.athoracsur.2021.05.060
Yang, Yu, Xu, Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study, Lancet Respir Med
Zimmermann, Bein, Arlt, Pumpless extracorporeal interventional lung assist in patients with acute respiratory distress syndrome: a prospective pilot study, Crit Care
Late treatment
is less effective
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop